View the latest SAMU supported publications from 2020.
Articles include:
From Q1:
- Lessons from the South African flucytosine access programme
- Emerging priorities for HIV service delivery
From Q2:
- Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath
- The ethical imperative to relieve suffering for people with tuberculosis by ensuring access to palliative care
- Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India
- Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa
- Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
- Improving pediatric TB diagnosis in North Kivu (DR Congo), focusing on a clinical algorithm including targeted Xpert MTB/RIF on gastric aspirates
- Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa
- Partner Notification Approaches for Sex Partners and Children of Human Immunodeficiency Virus Index Cases in Côte d'Ivoire
- Preventing tuberculosis in children: A global health emergency
- Retention and sustained viral suppression in HIV patients transferred to community refill centres in Kinshasa, DRC
- Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018
- Critical changes to services for TB patients during the COVID-19 pandemic
- The Enduring Burden of Advanced Human Immunodeficiency Virus Disease
- Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening
- Setting up a nurse-led model of care for management of hypertension and diabetes mellitus in a high HIV prevalence context in rural Zimbabwe
From Q3:
- OIM: Outreach initiation and Management
- The problem with vitamin D supplementation for tuberculosis
- The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide
- Adapting TB services during the COVID-19 pandemic in Mumbai, India
- How COVID-19 could benefit tuberculosis and HIV services in South Africa
- Successes and gaps in the HIV cascade of care of a high HIV prevalence setting in Zimbabwe: a population-based survey
- Preparedness of outpatient health facilities for ambulatory treatment with all-oral short DR-TB treatment regimens in Zhytomyr, Ukraine: a cross-sectional study
- Knowledge transmission, peer support, behaviour change and satisfaction in post Natal clubs in Khayelitsha, South Africa: a qualitative study
- Responding to SARS-CoV-2 in South Africa: what can we learn from drug- resistant tuberculosis?
- ‘Only twice a year’: a qualitative exploration of 6-month antiretroviral treatment refills in adherence clubs for people living with HIV in Khayelitsha, South Africa
- Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis
- Correspondence regarding “Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa”
From Q4:
- Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis
- Twenty-four-month outcomes from a cluster-randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs
- New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India
- Ending deaths from HIV-related cryptococcal meningitis Lancet 2030
- Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
- Adapting TB services during the COVID-19 pandemic in Mumbai, India
- “SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa
- Clinical perspectives on treatment of rifampicin-resistant/ multidrug-resistant TB
- Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?
- One step forward: Successful end-of-treatment outcomes of drugresistant TB patients who received concomitant bedaquiline and delamanid in Mumbai, India
- Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC)